Review Article
Prevalence of Obesity and Overweight among Adults in the Middle East Countries from 2000 to 2020: A Systematic Review and Meta-Analysis
Table 4
Population Attributable Risk for obesity by country and cardiovascular diseases.
| | Variables/PAR | Cardiovascular diseases | | Coronary heart disease (CAD) | Heart failure (HF) | Atrial fibrillation (AF) |
| | Countries | Kuwait | 5.4 (0.4–12.5) | 15.2 (7.1–25.7) | 12.8 (7.1–19.2) | | Israel | 4.2 (04–8.6) | 6.5 (6.2–18.5) | 10.0 (6.8–13.5) | | Saudi Arabia | 4.5 (0.4–10.6) | 12.9 (6.2–22.3) | 10.9 (6.8–16.4) | | Oman | 2.7 (0.09–12.5) | 7.9 (1.5–25.7) | 6.6 (1.7–19.2) | | Palestine | 4.2 (0.2–11.5) | 12.0 (4.5–24.0) | 10.0 (4.9–17.8) | | Yemen | 1.5 (0.1–3.9) | 4.7 (2.1–9.0) | 3.9 (2.3–6.3) | | United Arab Emirates | 4.3 (0.3–10.2) | 12.4 (5.4–21.7) | 10.4 (5.9–15.9) | | Turkey | 4.3 (0.3–9.9) | 12.4 (6.0–21.0) | 10.4 (6.5–15.5) | | Syria | 7.4 (0.6–15.8) | 19.8 (10.0–31.2) | 16.9 (10.9–23.8) | | Lebanon | 3.4 (0.2–9.6) | 10.0 (3.6–20.4) | 8.4 (4.0–15.0) | | Iraq | 5.4 (0.3–15.2) | 15.2 (5.4–30.3) | 12.8 (5.9–23.0) | | Cyprus | 4.3 (0.2–12.5) | 12.4 (4.5–25.7) | 10.4 (4.9–19.2) | | Bahrain | 0.3 (0.07–24.2) | 1.2 (1.2–43.5) | 1.0 (1.3–34.6) | | Jordan | 3.1 (0.1–9.5) | 9.0 (3.1–20.4) | 7.5 (3.3–15.0) | | Egypt | 4.0 (0.2–10.9) | 11.5 (4.5–22.8) | 9.6 (4.9–16.9) | | Iran | 4.2 (0.3–9.2) | 12.0 (5.7–19.8) | 10.0 (6.2–14.5) |
| | Sex | Female | 4.7 (0.4–9.9) | 13.4 (6.8–21.0) | 11.3 (7.4–15.5) | | Male | 3.6 (0.3–8.2) | 10.5 (5.1–16.7) | 8.8 (5.6–13.0) |
| | Total (Middle East) | 4.0 (0.3–9.6) | 11.5 (5.1–20.4) | 9.6 (5.6–15.0) |
|
|
